BioMed Research International
Volume 2020 (2020), Article ID 2453270, 2 pages
https://doi.org/10.1155/2020/2453270

Corrigendum

Corrigendum to “Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq”

Shaema Salih Amin,¹ Sana Dlawar Jalal,² Kosar Muhammed Ali,³ Ali Ibrahim Mohammed,² Luqman Khalid Rasool,⁴ and Tara Jamel Osman⁴

¹Sulaymaniyah Directorate of Health, Hewa Oncology Hospital, Sulaymaniyah, Iraq
²Department of Pathology, College of Medicine, University of Sulaymaniyah, Sulaymaniyah, Iraq
³Department of Medicine, College of Medicine, University of Sulaymaniyah, Sulaymaniyah, Iraq
⁴Thalassemia and Congenital Blood Disorders Center, Sulaymaniyah 46001, Iraq

Correspondence should be addressed to Sana Dlawar Jalal; dr.sanajalal612@gmail.com

Received 18 June 2020; Accepted 19 June 2020; Published 30 June 2020

Copyright © 2020 Shaema Salih Amin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq” [1], there was an error in Table 1. The corrected table is shown below and is listed as Table 1.

Table 1: Patient and disease characteristics of the current study.

Parameter
Frequency
Number of evaluated patients
Percent

Demographic data

Age (years)

    <18
90
159
56.6

    18-35
55
159
34.6

    >35
14
159
8.8

Gender

    Male
90
159
56.6

    Female
69
159
43.4

    Splenectomized
52
159
32.75

Serum ferritin (μg/L)

    <1000
122
159
76.7

    >1000
37
159
23.3

Treatment

    None transfused
33
159
20.7

    Occasional transfusion
75
159
47.2

    Regular transfusion
51
159
32.1

    Iron chelation
63
159
39.6

    Hydroxyurea
75
159
47.2

Complications

    Facial deformity
99
159
62.3

    Osteoporosis
17
60
28.3

    Growth retardation
25
90
27.8

    Subclinical hypothyroidism
22
131
16.8

    Cholelithiasis
19
137
13.8

    Pulmonary hypertension
18
159
11.3

    Abnormal liver function
12
159
7.5

    Thrombosis
2
159
1.3

    EMH
1
159
0.6

    Leg ulcer
1
159
0.6

Osteoporosis and subclinical hypothyroidism were evaluated in years old and/or symptomatic, growth retardation ( below 3rd percentile for the mean age and gender) in years, and cholelithiasis estimated in 137 patient excluding the 22 patients that underwent cholecystectomy.

References

S. S. Amin, S. D. Jalal, K. M. Ali, A. I. Mohammed, L. K. Rasool, and T. J. Osman, “Beta-thalassemia intermedia: a single thalassemia center experience from northeastern Iraq,” BioMed Research International, vol. 2020, Article ID 2807120, 11 pages, 2020.